SMAD4 and adenoma: In summary, we identified TGF-β and SMAD4 gene expression signatures in mouse adenoma, both for bulk and single cell sequencing, that require future prospective evaluation of pathway based prognostic-predictive classifiers across intestinal cancer subtypes4.